# Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer

> **NCT02092948** · PHASE1 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer
- Pancreatic Cancer
- Bladder Cancer

## Interventions

- **RADIATION:** [124I] PSCA-Minibody PET/CT imaging of the whole body

## Key facts

- **NCT ID:** NCT02092948
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-22
- **Primary completion:** 2017-01-06
- **Final completion:** 2017-01-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02092948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02092948, "Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02092948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*